Cargando…

Practical considerations for optimising homologous recombination repair mutation testing in patients with metastatic prostate cancer

Analysis of the genomic landscape of prostate cancer has identified different molecular subgroups with relevance for novel or existing targeted therapies. The recent approvals of the poly(ADP‐ribose) polymerase (PARP) inhibitors olaparib and rucaparib in the metastatic castration‐resistant prostate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gonzalez, David, Mateo, Joaquin, Stenzinger, Albrecht, Rojo, Federico, Shiller, Michelle, Wyatt, Alexander W, Penault‐Llorca, Frédérique, Gomella, Leonard G, Eeles, Ros, Bjartell, Anders
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185363/ https://www.ncbi.nlm.nih.gov/pubmed/33630412 http://dx.doi.org/10.1002/cjp2.203

Ejemplares similares

Implementing TMB measurement in clinical practice: considerations on assay requirements
por: Büttner, Reinhard, et al.
Publicado: (2019)

Accurate tumor purity determination is critical for the analysis of homologous recombination deficiency (HRD)
por: Menzel, Michael, et al.
Publicado: (2023)

Homologous Recombination Deficiency: Concepts, Definitions, and Assays
por: Stewart, Mark D, et al.
Publicado: (2022)

Controversies in oncology: are genomic tests quantifying homologous recombination repair deficiency (HRD) useful for treatment decision making?
por: Pellegrino, Benedetta, et al.
Publicado: (2019)

Homologous recombination deficiency is inversely correlated with microsatellite instability and identifies immunologically cold tumors in most cancer types
por: Budczies, Jan, et al.
Publicado: (2022)

Comparison of different commercial kits for HER2 testing in breast cancer: looking for the accurate cutoff for amplification
por: Cayre, Anne, et al.
Publicado: (2007)

aHIF but not HIF-1α transcript is a poor prognostic marker in human breast cancer
por: Cayre, Anne, et al.
Publicado: (2003)

Testing algorithm for identification of patients with TRK fusion cancer
por: Penault-Llorca, Frédérique, et al.
Publicado: (2019)

From Targeting Somatic Mutations to Finding Inherited Cancer Predispositions: The Other Side of the Coin
por: Pujol, Pascal, et al.
Publicado: (2019)

P-gp expression in brown trout erythrocytes: evidence of a detoxification mechanism in fish erythrocytes
por: Valton, Emeline, et al.
Publicado: (2013)

Simulation and Optimisation of CLIC's recombination complex
por: Costa, Raul
Publicado: (2018)

Circulating proteins as predictive and prognostic biomarkers in breast cancer
por: Veyssière, Hugo, et al.
Publicado: (2022)

Toward More Comprehensive Homologous Recombination Deficiency Assays in Ovarian Cancer, Part 1: Technical Considerations
por: Quesada, Stanislas, et al.
Publicado: (2022)

Mini-P-gp and P-gp Co-Expression in Brown Trout Erythrocytes: A Prospective Blood Biomarker of Aquatic Pollution
por: Valton, Emeline, et al.
Publicado: (2015)

Breaking down the Contradictory Roles of Histone Deacetylase SIRT1 in Human Breast Cancer
por: Rifaï, Khaldoun, et al.
Publicado: (2018)

Co-targeting EGFR and mTOR with gefitinib and everolimus in triple-negative breast cancer cells
por: El Guerrab, Abderrahim, et al.
Publicado: (2020)

Defective homologous recombination DNA repair as therapeutic target in advanced chordoma
por: Gröschel, Stefan, et al.
Publicado: (2019)

Rapid and quantitative detection of homologous and non-homologous recombination events using three oligonucleotide MLPA
por: Langerak, Petra, et al.
Publicado: (2005)

Optimisation in the Design of Environmental Sensor Networks with Robustness Consideration
por: Budi, Setia, et al.
Publicado: (2015)

Optimisation of Recombinant Myrosinase Production in Pichia pastoris
por: Rosenbergová, Zuzana, et al.
Publicado: (2021)

Optimising expression and extraction of recombinant proteins in plants
por: Coates, Ryan J., et al.
Publicado: (2022)

Interest and Limits of [(18)F]ML-10 PET Imaging for Early Detection of Response to Conventional Chemotherapy
por: Jouberton, Elodie, et al.
Publicado: (2021)

Homologous recombination and its regulation
por: Krejci, Lumir, et al.
Publicado: (2012)

BRCA2 and homologous recombination
por: Orelli, Brian J, et al.
Publicado: (2001)

Homologous Recombination: To Fork and Beyond
por: Prado, Félix
Publicado: (2018)

The Regulation of Homologous Recombination by Helicases
por: Huselid, Eric, et al.
Publicado: (2020)

Structural basis of homologous recombination
por: Sun, Yueru, et al.
Publicado: (2019)

Pan-cancer Analysis of Homologous Recombination Repair–associated Gene Alterations and Genome-wide Loss-of-Heterozygosity Score
por: Westphalen, C. Benedikt, et al.
Publicado: (2022)

Anti-EGFR monoclonal antibodies and EGFR tyrosine kinase inhibitors as combination therapy for triple-negative breast cancer
por: Guerrab, Abderrahim El, et al.
Publicado: (2016)

PARP Inhibitors: A Major Therapeutic Option in Endocrine-Receptor Positive Breast Cancers
por: Collet, Laetitia, et al.
Publicado: (2022)

Manual para el residente y el internado rotatorio
por: Gomella, Leonard G.
Publicado: (1990)

Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers
por: Fkih M’hamed, Insaf, et al.
Publicado: (2015)

Hotspots of homologous recombination in the human genome: not all homologous sequences are equal
por: Lupski, James R
Publicado: (2004)

Impact of homologous and non-homologous recombination in the genomic evolution of Escherichia coli
por: Didelot, Xavier, et al.
Publicado: (2012)

Homologous Recombination and Its Role in Carcinogenesis
por: Bishop, Alexander J. R., et al.
Publicado: (2002)

Investigations of Homologous Recombination Pathways and Their Regulation
por: Daley, James M., et al.
Publicado: (2013)

Creating Hybrid Genes by Homologous Recombination
por: Wang, Peter L.
Publicado: (2000)

Initiation of homologous recombination at DNA nicks
por: Maizels, Nancy, et al.
Publicado: (2018)

The many facets of homologous recombination at telomeres
por: Claussin, Clémence, et al.
Publicado: (2015)

Homologous Recombination Deficiencies and Hereditary Tumors
por: Yamamoto, Hideki, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f2s35tpan057b672rc5e2ujl5g